大北农前三季度净利润同比增长92.56% 书写科技创新答卷

Core Viewpoint - Beijing Dabeinong Technology Group Co., Ltd. reported a revenue of 20.744 billion yuan for the first three quarters of 2023, a year-on-year increase of 2.99%, and a net profit attributable to shareholders of 257 million yuan, a significant year-on-year increase of 92.56% [1] Group 1: Company Performance - The company has established a comprehensive business system covering six major sectors, including biotechnology and seed breeding, with a network of 50 subsidiaries [1] - Dabeinong's seed sales in 2024 are projected to reach 53.526 million kilograms, covering over 40 million mu of farmland and serving 750,000 farmers [1] Group 2: Research and Development - Dabeinong has a research team of over 2,600 people, accounting for more than 16% of its total workforce, with R&D investment of 734 million yuan in 2024, representing 2.55% of revenue [2] - The company has received six national science and technology progress awards, including one special prize and one first prize [2] Group 3: Innovation Strategy - Dabeinong has developed a clear "532" strategy and "2+4+X" matrix for innovation, emphasizing a balanced approach to independent innovation and collaboration [3] - The company implements three paths for achieving innovation: independent research and development, technology introduction, and industry-university-research cooperation [4] Group 4: Product Development and Market Strategy - Dabeinong focuses on full-chain layout and brand operation, exemplified by its flagship product "Dayougu," which aims to provide safer and more nutritious food [5] - The company is committed to driving modern agriculture towards high yield, quality, green, and low-carbon futures through its dual engines of biological breeding and manufacturing [5][6] Group 5: Global Vision and Strategic Alignment - Dabeinong's "Seed Out Bean In" plan in South America has evolved into a "Technology Out Grain In" strategy, showcasing its global perspective and capabilities [5] - The company is aligning its strategic layout with national priorities, particularly in the field of biological manufacturing, which has been identified as a key future industry by the National Development and Reform Commission [6]